Author

Manon Teisseire

Centre National de la Recherche ScientifiqueORCID 0000-0002-0035-0532Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Cancer Biology· 2

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:cancer & tumor microenvironment· 2 Approach:experimental assay· 2 Organism:human· 2 Assay:bulk RNA-seq· 1 Research Focus:metabolism & bioenergetics· 1 Assay:metabolomics· 1

Frequent Co-Authors

Gilles PagèsiD· 2 shared Sandy GiulianoiD· 2 shared Alexandrine CarminatiiD· 1 shared Arthur GouraudiD· 1 shared Christophe BontouxiD· 1 shared Clément MolinaiD· 1 shared Coline Savy· 1 shared Frédéric LucianoiD· 1 shared

Activity by Year

2024-2025 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 29 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersCancer Biology

Gilles PagèsORCID

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Exploiting De Novo Serine Synthesis as a Metabolic Vulnerability to Overcome Sunitinib Resistance in Advanced Renal Cell Carcinoma

Manon Teisseire, Umakant Sahu, Julien Parola, Meng‐Chen Tsai, Valérie Vial, Jérôme Durivault, Renaud Grépin, Yann Cormerais, Clément Molina, Arthur Gouraud, Gilles Pagès, Issam Ben‐Sahra, Sandy Giuliano

This study identifies serine synthesis as a metabolic vulnerability in sunitinib-resistant renal cell carcinoma, showing that inhibiting key enzymes enhances drug sensitivity.

Cancer Research · Mar 3, 2025Peer-reviewedCancer Biology

Disrupting USP39 deubiquitinase Function Impairs the Survival and Migration of Multiple Myeloma Cells through ZEB1 Degradation

Jessy Sirera, Saharnaz Sarlak, Manon Teisseire, Alexandrine Carminati, Coline Savy, Victoria J. Nicolini, Patrick Brest, Thierry Juel, Christophe Bontoux, Marcel Deckert, Mickaël Ohanna, Sandy Giuliano, Maeva Dufies, Gilles Pagès, Frédéric Luciano

This study identifies USP39 as a critical survival and migration factor in multiple myeloma cells, showing that its disruption leads to ZEB1 degradation and reduced tumor growth.

Journal of Experimental & Clinical Cancer Research · Dec 30, 2024Peer-reviewedCancer Biology